
Charles River Laboratories Completes the Acquisition of Cognate BioServices
WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed...
Find Out More
Cobra provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced Advanced Therapies project teams nurturing customers’ plasmid DNA, viral vector and microbiota products from pre-clinical through to clinical and commercial manufacture within GMP approved facilities.
WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed...
Find Out MoreThomas Moore, Science and Medical Correspondent Sky News, is joined by Prof. Lindy Durrant, immunologist and joint CEO/CSO of Scancell, and Alex...
Find Out MoreProviding large scale manufacturing capacity for AZD1222
Find Out MoreCobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.
Keep up to date with the latest news from Cobra Biologics